OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021
Andrew D. Zelenetz, Leo I. Gordon, Julie Chang, et al.
Journal of the National Comprehensive Cancer Network (2021) Vol. 19, Iss. 11, pp. 1218-1230
Open Access | Times Cited: 131
Andrew D. Zelenetz, Leo I. Gordon, Julie Chang, et al.
Journal of the National Comprehensive Cancer Network (2021) Vol. 19, Iss. 11, pp. 1218-1230
Open Access | Times Cited: 131
Showing 1-25 of 131 citing articles:
CAR-T Cell Therapy in Hematological Malignancies: Current Opportunities and Challenges
Xiaomin Zhang, Lingling Zhu, Hui Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 213
Xiaomin Zhang, Lingling Zhu, Hui Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 213
Fluorine-containing drugs approved by the FDA in 2021
Jingrui He, Ziyi Li, Gagan Dhawan, et al.
Chinese Chemical Letters (2022) Vol. 34, Iss. 1, pp. 107578-107578
Closed Access | Times Cited: 113
Jingrui He, Ziyi Li, Gagan Dhawan, et al.
Chinese Chemical Letters (2022) Vol. 34, Iss. 1, pp. 107578-107578
Closed Access | Times Cited: 113
International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors
Edward C. Kuan, Eric Wang, Nithin D. Adappa, et al.
International Forum of Allergy & Rhinology (2023) Vol. 14, Iss. 2, pp. 149-608
Open Access | Times Cited: 56
Edward C. Kuan, Eric Wang, Nithin D. Adappa, et al.
International Forum of Allergy & Rhinology (2023) Vol. 14, Iss. 2, pp. 149-608
Open Access | Times Cited: 56
Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy
Ahmet Bilgehan Şahin, Erdem Çubukçu, Birol Ocak, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 83
Ahmet Bilgehan Şahin, Erdem Çubukçu, Birol Ocak, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 83
Integration of Genomic Biology Into Therapeutic Strategies of Gastric Cancer Peritoneal Metastasis
Yong Xiang Gwee, Daryl Kai Ann Chia, Jimmy Bok Yan So, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 24, pp. 2830-2830
Open Access | Times Cited: 58
Yong Xiang Gwee, Daryl Kai Ann Chia, Jimmy Bok Yan So, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 24, pp. 2830-2830
Open Access | Times Cited: 58
PET/CT in Non-Hodgkin Lymphoma: An Update
Lucia Zanoni, Davide Bezzi, Cristina Nanni, et al.
Seminars in Nuclear Medicine (2022) Vol. 53, Iss. 3, pp. 320-351
Closed Access | Times Cited: 42
Lucia Zanoni, Davide Bezzi, Cristina Nanni, et al.
Seminars in Nuclear Medicine (2022) Vol. 53, Iss. 3, pp. 320-351
Closed Access | Times Cited: 42
Zanubrutinib: past, present, and future
Constantine S. Tam, Javier Muñoz, John F. Seymour, et al.
Blood Cancer Journal (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 25
Constantine S. Tam, Javier Muñoz, John F. Seymour, et al.
Blood Cancer Journal (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 25
Global patterns of non‐Hodgkin lymphoma in 2020
Allini Mafra da Costa, Mathieu Laversanne, Mary Gospodarowicz, et al.
International Journal of Cancer (2022) Vol. 151, Iss. 9, pp. 1474-1481
Closed Access | Times Cited: 35
Allini Mafra da Costa, Mathieu Laversanne, Mary Gospodarowicz, et al.
International Journal of Cancer (2022) Vol. 151, Iss. 9, pp. 1474-1481
Closed Access | Times Cited: 35
The Minimal Residual Disease Using Liquid Biopsies in Hematological Malignancies
Rafael Colmenares, Noemí Álvarez, Santiago Barrio, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1310-1310
Open Access | Times Cited: 27
Rafael Colmenares, Noemí Álvarez, Santiago Barrio, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1310-1310
Open Access | Times Cited: 27
Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma
Loretta J. Nastoupil, Georg Heß, Miguel Arturo Pavlovsky, et al.
Blood Advances (2023) Vol. 7, Iss. 22, pp. 7141-7150
Open Access | Times Cited: 15
Loretta J. Nastoupil, Georg Heß, Miguel Arturo Pavlovsky, et al.
Blood Advances (2023) Vol. 7, Iss. 22, pp. 7141-7150
Open Access | Times Cited: 15
Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing
Ryan Ptashkin, Mark D. Ewalt, Gowtham Jayakumaran, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 15
Ryan Ptashkin, Mark D. Ewalt, Gowtham Jayakumaran, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 15
Second primary malignancies in patients with lymphoma in Denmark after high-dose chemotherapy and autologous haematopoietic stem-cell transplantation: a population-based, retrospective cohort study
Trine Trab, Joachim Bæch, Lasse Jakobsen, et al.
The Lancet Haematology (2023) Vol. 10, Iss. 10, pp. e838-e848
Closed Access | Times Cited: 14
Trine Trab, Joachim Bæch, Lasse Jakobsen, et al.
The Lancet Haematology (2023) Vol. 10, Iss. 10, pp. e838-e848
Closed Access | Times Cited: 14
Diagnosis and management of mantle cell lymphoma: A British Society for Haematology Guideline
Toby A. Eyre, Mark Bishton, Rory McCulloch, et al.
British Journal of Haematology (2023) Vol. 204, Iss. 1, pp. 108-126
Closed Access | Times Cited: 14
Toby A. Eyre, Mark Bishton, Rory McCulloch, et al.
British Journal of Haematology (2023) Vol. 204, Iss. 1, pp. 108-126
Closed Access | Times Cited: 14
The Gut Microbiome Correlated to Chemotherapy Efficacy in Diffuse Large B-Cell Lymphoma Patients
Zhuofan Xu, Yuan Li, Yan Zhang, et al.
Hematology Reports (2024) Vol. 16, Iss. 1, pp. 63-75
Open Access | Times Cited: 5
Zhuofan Xu, Yuan Li, Yan Zhang, et al.
Hematology Reports (2024) Vol. 16, Iss. 1, pp. 63-75
Open Access | Times Cited: 5
Implications of Sarcopenia and Glucometabolism Parameters of Muscle Derived From Baseline and End-of-Treatment 18F-FDG PET/CT in Diffuse Large B-Cell Lymphoma
Xiaoyue Tan, Xiaolin Sun, Chen Yang, et al.
Korean Journal of Radiology (2024) Vol. 25, Iss. 3, pp. 277-277
Open Access | Times Cited: 5
Xiaoyue Tan, Xiaolin Sun, Chen Yang, et al.
Korean Journal of Radiology (2024) Vol. 25, Iss. 3, pp. 277-277
Open Access | Times Cited: 5
Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study
Paola Ghione, M. Lia Palomba, Hervé Ghesquières, et al.
Haematologica (2022) Vol. 108, Iss. 3, pp. 822-832
Open Access | Times Cited: 21
Paola Ghione, M. Lia Palomba, Hervé Ghesquières, et al.
Haematologica (2022) Vol. 108, Iss. 3, pp. 822-832
Open Access | Times Cited: 21
Overcoming chimeric antigen receptor-T (CAR-T) resistance with checkpoint inhibitors: Existing methods, challenges, clinical success, and future prospects: A comprehensive review
Kartik Tulsian, Dhruma Thakker, Vivek K. Vyas
International Journal of Biological Macromolecules (2025), pp. 141364-141364
Closed Access
Kartik Tulsian, Dhruma Thakker, Vivek K. Vyas
International Journal of Biological Macromolecules (2025), pp. 141364-141364
Closed Access
Managing HIV-Associated Hodgkin Lymphoma During the COVID-19 Pandemic: Case Report and Literature Review
Monica-Daniela Padurariu-Covit, Mihaela Andreescu, Elena Niculeț, et al.
Viruses (2025) Vol. 17, Iss. 3, pp. 404-404
Open Access
Monica-Daniela Padurariu-Covit, Mihaela Andreescu, Elena Niculeț, et al.
Viruses (2025) Vol. 17, Iss. 3, pp. 404-404
Open Access
A viral infection prediction model for patients with r/r B-cell malignancies after CAR-T therapy: a retrospective analysis
Shujing Guo, Jile Liu, Bing Wang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Shujing Guo, Jile Liu, Bing Wang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Differences in clinical characteristics and outcomes between patients with grade 3a and grades 1–2 follicular lymphoma: a real-world multicenter study
Jie Zha, Qinwei Chen, Jingjing Ye, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 9
Jie Zha, Qinwei Chen, Jingjing Ye, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 9
Baseline 18F-FDG PET/CT may contribute to the determination of initial treatment strategy for newly diagnosed follicular lymphoma
Qiao Yang, Hongzhe Zhang, Yan Zhang, et al.
European Journal of Radiology (2024) Vol. 178, pp. 111632-111632
Closed Access | Times Cited: 3
Qiao Yang, Hongzhe Zhang, Yan Zhang, et al.
European Journal of Radiology (2024) Vol. 178, pp. 111632-111632
Closed Access | Times Cited: 3
Semiquantitative 2-[18F]FDG PET/CT-based parameters role in lymphoma
Domenico Albano, Marco Ravanelli, Rexhep Durmo, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 3
Domenico Albano, Marco Ravanelli, Rexhep Durmo, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 3
Ultrasonography‐guided core‐needle biopsy of lymphadenopathies suspected of lymphoma: Analysis on diagnostic efficacy and safety of 1000 front‐line biopsies in a multicenter Italian study
Marco Picardi, Claudia Giordano, Elena Vigliar, et al.
Hematological Oncology (2023) Vol. 41, Iss. 5, pp. 817-827
Open Access | Times Cited: 9
Marco Picardi, Claudia Giordano, Elena Vigliar, et al.
Hematological Oncology (2023) Vol. 41, Iss. 5, pp. 817-827
Open Access | Times Cited: 9
Role of body composition and metabolic parameters extracted from baseline 18F-FDG PET/CT in patients with diffuse large B-cell lymphoma
Chen Yang, Zhijian Chen, Xiaoyue Tan, et al.
Annals of Hematology (2023) Vol. 102, Iss. 10, pp. 2779-2789
Closed Access | Times Cited: 8
Chen Yang, Zhijian Chen, Xiaoyue Tan, et al.
Annals of Hematology (2023) Vol. 102, Iss. 10, pp. 2779-2789
Closed Access | Times Cited: 8
Efficacy of front-line immunochemotherapy for follicular lymphoma: a network meta-analysis of randomized controlled trials
Yucai Wang, Shouhao Zhou, Xinyue Qi, et al.
Blood Cancer Journal (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 13
Yucai Wang, Shouhao Zhou, Xinyue Qi, et al.
Blood Cancer Journal (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 13
